Pancreatic adenocarcinoma represents a growing problem in Western countries due to its increasing incidence, difficult early diagnosis related to nonspecific symptoms, and intrinsic aggressiveness that translates into low overall survival (≈12% at 5 years), whereas neuroendocrine tumors (NETs) generally show a better prognosis and, in the pancreas, account for only ~2% of pancreatic neoplasms; the synchronous coexistence of both within the spectrum of multiple primary tumors (5–10% in the population) is exceptional. In this context, and with the participation of CISeAL principal investigators Dr. Ruth Jimbo-Sotomayor and Dr. Xavier Sanchez, we document the case of a 52-year-old man with type 2 diabetes who presented with three weeks of abdominal pain, weight loss, and anorexia without jaundice; laboratory studies showed mild hyperbilirubinemia, elevated transaminases, and a cholestatic pattern, and MRCP plus angiotomography revealed dilation of the bile duct and duct of Wirsung along with an 18 mm lesion in the pancreatic head without vascular invasion, clinically staged as IA. After ERCP biliary stent placement and preoperative evaluation, a robot-assisted cephalic duodenopancreatectomy (Whipple procedure) was performed, allowing precise dissection and lymphadenectomy; the postoperative course was uneventful. Histopathology identified a moderately differentiated adenocarcinoma with perineural and lymphovascular invasion, three negative nodes, and pathologic stage IB (pT2 pN0 pMX), as well as a separate incidental finding: a well-differentiated neuroendocrine tumor confined to the pancreatic head (pT1 pN0 pMX) with a low proliferative index, constituting a synchronous collision-type (biphasic) tumor and not a mixed neuroendocrine–nonendocrine neoplasm (MiNEN), in which both components should be admixed and each represent >30% of the mass. The patient received six cycles of FOLFOXIRI chemotherapy over eight months and then concurrent chemoradiotherapy with capecitabine (total dose 50.4 Gy at 13 months) and continues to do well, with no evidence of tumor activity on quarterly follow-up.
The most recent research in which CISeAL principal investigators Dr. Anita Villacís and Dr. Mario Grijalva participated sheds new light on the evolution of the group of insect vectors of Trypanosoma cruzi belonging to the tribe Rhodniini, fundamental in the transmission of Chagas disease. Through an unprecedented multilocus phylogenetic analysis, which included eight genes in 497 specimens of 17 species collected in seven countries, it was revealed that the current classification of this group does not reflect its evolutionary history. The paraphyly of the genus Rhodnius is confirmed, with the three species of the genus Psammolestes forming a monophyletic clade within it, although some alternative analyses position them as distinct sister groups. The prolixus group was found not to be monophyletic, in contrast to the pictipes and pallescens groups, which did show phylogenetic coherence. The divergence of the common ancestor of Rhodniini would have occurred approximately 5.26 million years ago, indicating a more recent origin than previously proposed, with key diversification events coinciding with Pleistocene climatic changes. Only four species—P. arthuri, R. ecuadoriensis, R. neivai, and R. neglectus—were consistently delimited as clear evolutionary units, calling into question the number of valid species recognized in the tribe.
The article, in which Miryan Rivera, a CISeAL researcher, participates together with her laboratory technician Mateo Salazar, presents a green and efficient synthesis strategy for obtaining carbon dots (CDs) from natural products such as annatto (Bixa orellana), cinnamon (Cinnamomum verum), and turmeric (Curcuma longa), using a microwave-assisted technique that stands out for its speed, simplicity, and environmental compatibility. Four types of CDs (CDs1, CDs2, CDs3, and CDs4) were generated from aqueous dispersions of these extracts and sucrose, and were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FTIR), and Raman spectroscopy. The obtained CDs presented irregular shapes and sizes ranging from 2.3 to 3.7 nanometers, exhibiting luminescent and photoactivated properties with the ability to generate singlet reactive oxygen species (¹O₂) and produce temperature increases between 40 and 50 °C upon irradiation with blue light (450 nm, 40 mW·cm⁻²).
In her most recent publication, Dr. Anita G. Villacís, Principal Investigator at CISeAL, examines how environmental contamination influences the ecology of the vector Rhodnius ecuadoriensis in wild areas of southern Ecuador. Traditionally associated with wild environments, this insect has begun to adapt to human-influenced habitats, which represents a growing challenge for the control of Chagas disease.
This research had the outstanding participation of Jazive Esparza, under the direction of Dr. Anita G. Villacís, in collaboration with experts such as Soledad Santillán-Guayasamín, César A. Yumiseva, Juan José Bustillos, Mario J. Grijalva, and Sereno Denis.
The study analyzed 389 nests collected in eight communities in the province of Loja during 2018, 2022, and 2023, differentiating between peridomestic and wild nests. The findings reveal a drastic reduction in the infestation rate in areas close to dwellings (from 33.3% in 2018 to 0% in 2022), while wild areas maintained fluctuating levels. A significant association was identified between triatomine infestation and mammal nests, many of which contained anthropogenic materials—especially near roads and other human-intervened areas.
Dr. Betzabé Tello, principal researcher at CISeAL-PUCE, was part of the academic team that recently published a study that validated in Ecuador the use of the NOVA 27 Ultra-Processed Food Screener, a tool developed internationally and adapted to the Ecuadorian context. This questionnaire allows for a quick and reliable estimation of the consumption of ultra-processed products in adults.
The study was led by Dr. Wilma Freire of the Universidad San Francisco de Quito and included the participation of Dr. Philippe Belmont, adjunct researcher at CISeAL, who was in charge of the statistical validation of the instrument.
The results are framed in a context of food transition, where ultra-processed products such as soft drinks, snacks, industrial bread, sausages, and ready-to-eat meals are displacing fresh foods and traditional preparations. This increasing exposure to ultra-processed foods deteriorates the quality of the diet and affects health from an early age.
The study was developed in two phases: first, an online validation with 327 adults in Quito, and then a comparative analysis with data from the National Health and Nutrition Survey (ENSANUT-Ecu 2012), which included 3,510 adults.
One of the key findings was that the 27 food groups included in the questionnaire account for 90% of the calories coming from ultra-processed products, which confirms that the instrument efficiently captures the habitual consumption of this type of product. In other words, although there are many types of ultra-processed products on the market, the 27 subgroups selected for the screener concentrate almost all the caloric energy that comes from this type of product in the diet of Ecuadorian adults.
Published in The Lancet Global Health, one of the highest-impact scientific journals in the field of public health, this international study, with the participation of Dr. Ana Lucia Moncayo, principal investigator at CISeAL, analyzes the effects of the Bolsa Família Program (BFP) in Brazil on mortality and hospitalization over two decades, with projections up to 2030. The BFP, one of the largest and longest-running conditional cash transfer (CCT) programs in the world, has benefited more than 50 million people through monthly transfers subject to the fulfillment of key health and education indicators.
Using multivariate Poisson models with fixed effects, applied to data from 3,671 Brazilian municipalities between 2000 and 2019, the study identified that high program coverage was associated with a significant reduction in the age-standardized mortality rate (RR 0.824), while high benefit adequacy also contributed to a relevant decrease (RR 0.849). It is estimated that the BFP prevented more than 8.2 million hospitalizations and over 713,000 deaths during that period, with particularly marked effects on the reduction of infant mortality and hospitalizations of people over 70 years of age.
